Le Lézard
Classified in: Business
Subjects: PER, CXP

The OmbudService for Life & Health Insurance Enhances Focus on Western Canada


Canada's independent insurance complaint resolution service appoints new
Regional Head of Communications and Marketing for Western Canada

TORONTO, Feb. 4, 2020 /CNW/ - The OmbudService for Life & Health Insurance (OLHI) is pleased to announce the appointment of Kim Alison Fraser as the new Regional Head of Communications and Marketing effective immediately, reporting to OLHI CEO & Ombudsman Glenn O'Farrell.

OmbudService for Life & Health Insurance (CNW Group/OmbudService for Life & Health Insurance)

"The work that OLHI does for Canadians is vital," says Kim Alison Fraser. OLHI is a free service for consumers: an independent resource where Canadians can have their life and health insurance disputes reviewed. "I am thrilled to have been selected to help build OLHI brand awareness across Western Canada."

"Ensuring all Canadians have full access to the insurance dispute resolution services OLHI provides is central to our mission," says OLHI CEO & Ombudsman Glenn O'Farrell. "In addition to serving at the helm of the communications and marketing practice for OLHI, Kim Alison Fraser will lead an Edmonton office focused on outreach to life and health insurance consumers across Western Canada."

Fraser brings her strategic communications and digital marketing expertise to the national, independent complaints resolution enterprise for the life and health insurance sector.

She is a marketing communications consultant with extensive experience building in-house marketing communications competencies for regional organizations including Banff Lake Louise Tourism, Culture Days and the Alberta University of the Arts (formerly Alberta College of Art + Design).

Fraser began her career in New York City after completing a Master's Degree in Journalism at Columbia University. She later went on to leadership roles in Toronto with organizations such as Microsoft, Rogers Media and Transcontinental Media. She brings her transformative leadership style and insights-led approach to this newly created role.

About the OmbudService for Life & Health Insurance
The OmbudService for Life & Health Insurance (OLHI) is Canada's independent complaint resolution and information service for consumers of Canadian life and health insurance. This includes life, disability, employee health benefits, travel, and insurance investment products such as annuities and segregated funds. OLHI's free, bilingual services are available to any consumer whose life or health insurer is an OLHI member; currently, 99% of Canadian life and health insurers are OLHI members. To ensure impartiality, OLHI operations are overseen by the Canadian Council of Insurance Regulators (CCIR). For more information, visit www.olhi.ca.

SOURCE OmbudService for Life & Health Insurance


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: